Nutex Health (NUTX) Fundamentals 2026 — P/E 11.7x, Revenue Analysis | SniperIQ

57.35 on the NASDAQ. This SniperIQ fundamentals page covers Nutex Health's valuation (P/E 11.7x, P/B 3.0x), profitability (net margin 11.0%), revenue ($875M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Nutex Health's market cap?

Nutex Health (NUTX) has a market capitalization of approximately $937M, trading at

57.35 on the NASDAQ. Market cap moves with the live share price.

What is Nutex Health's P/E ratio?

Nutex Health's trailing twelve-month P/E ratio is 11.7x, with a price-to-book (P/B) of 3.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Nutex Health?

Nutex Health runs a net profit margin of 11.0%, a gross margin of 47.5%, and an operating margin of 31.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Nutex Health generate?

Nutex Health reported revenue of $875M for fiscal year 2025, with net income of $71M and earnings per share (EPS) of 11.13. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Nutex Health pay a dividend?

Nutex Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Nutex Health financially healthy?

Nutex Health carries a debt-to-equity ratio of 1.01x and a current ratio of 3.14x, with a market beta of 1.97. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Nutex Health a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Nutex Health (NUTX) the key facts are: market cap $937M, P/E 11.7x, revenue $875M, 52-week range 77.21-204. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.